ARMETHEON INC has a total of 20 patent applications. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), Hong Kong and Israel. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are BEIJING INCREASE INNOVATIVE DRUG RES CO LTD, DJAMGOZ MUSTAFA BILGIN ALI and OOO KONSORTSIUM PIK.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Hong Kong | 3 | |
#3 | Israel | 3 | |
#4 | United States | 3 | |
#5 | Australia | 2 | |
#6 | Norway | 2 | |
#7 | Brazil | 1 | |
#8 | Taiwan | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Becker Cyrus | 7 |
#2 | Druzgala Pascal | 7 |
#3 | Druzgala Pascal J | 4 |
#4 | Pang Ponny | 2 |
#5 | By Kolbot | 2 |
#6 | Cooper Art | 2 |
#7 | Ellis David J | 2 |
#8 | Tien Jien-Heh J | 2 |
#9 | Yeh J B | 2 |
#10 | Palme Monica | 1 |
Publication | Filing date | Title |
---|---|---|
WO2014143625A1 | Budiodarone formulations | |
US2013143861A1 | Methods for treating atrial fibrillation | |
EP2161261A1 | Materials and methods for treating coagulation disorders |